Literature DB >> 22249572

An update on the diagnosis and management of dementing conditions.

Marwan Maalouf1, John M Ringman, Jiong Shi.   

Abstract

Worsening memory is a common complaint in the elderly and predictably causes affected individuals and their families to wonder whether the underlying cause is Alzheimer disease, the most common form of dementia. Alzheimer disease is a devastating illness that unavoidably leads to a complete loss of independence and, as a result, substantial emotional, physical, and financial distress for patients and their families. The causes and severity of memory impairment in the elderly are diverse, however, so any given case might not necessarily be secondary to a neurodegenerative disorder such as Alzheimer disease. Consequently, it is critical to rule out potentially reversible causes of dementia and to initiate treatment while cognitive and functional deficits are still mild and more likely to respond to treatment. Furthermore, identifying the etiology and defining a suitable treatment plan early in the course of dementia allows patients to be more actively involved in the management of their disease and is more likely to improve quality of life for both patients and caregivers. This review presents the etiology of dementia in the elderly, describes the diagnostic process, and discusses current therapeutic strategies, including pharmacological agents, nonpharmacological interventions, safety assessments, legal issues, and caregiver needs.

Entities:  

Mesh:

Year:  2011        PMID: 22249572      PMCID: PMC4096631     

Source DB:  PubMed          Journal:  Rev Neurol Dis        ISSN: 1545-2913


  94 in total

Review 1.  CT and MRI rating of white matter lesions.

Authors:  Franz Fazekas; F Barkhof; L O Wahlund; L Pantoni; T Erkinjuntti; P Scheltens; R Schmidt
Journal:  Cerebrovasc Dis       Date:  2002       Impact factor: 2.762

Review 2.  Behavioral effects of current Alzheimer's disease treatments: a descriptive review.

Authors:  Jeffrey L Cummings; Joan Mackell; Daniel Kaufer
Journal:  Alzheimers Dement       Date:  2008-01       Impact factor: 21.566

Review 3.  Early behavioral symptoms and course of Alzheimer's disease.

Authors:  M F Weiner; L S Hynan; M E Bret; C White
Journal:  Acta Psychiatr Scand       Date:  2005-05       Impact factor: 6.392

4.  Cognitive function over time in the Alzheimer's Disease Anti-inflammatory Prevention Trial (ADAPT): results of a randomized, controlled trial of naproxen and celecoxib.

Authors:  Barbara K Martin; Christine Szekely; Jason Brandt; Steven Piantadosi; John C S Breitner; Suzanne Craft; Denis Evans; Robert Green; Michael Mullan
Journal:  Arch Neurol       Date:  2008-05-12

5.  Risk factors for falls among elderly persons living in the community.

Authors:  M E Tinetti; M Speechley; S F Ginter
Journal:  N Engl J Med       Date:  1988-12-29       Impact factor: 91.245

6.  Normal pressure hydrocephalus: long-term outcome after shunt surgery.

Authors:  S Pujari; S Kharkar; P Metellus; J Shuck; M A Williams; D Rigamonti
Journal:  J Neurol Neurosurg Psychiatry       Date:  2008-03-20       Impact factor: 10.154

Review 7.  The neuroprotective properties of calorie restriction, the ketogenic diet, and ketone bodies.

Authors:  Marwan Maalouf; Jong M Rho; Mark P Mattson
Journal:  Brain Res Rev       Date:  2008-09-25

Review 8.  Research on treating neuropsychiatric symptoms of advanced dementia with non-pharmacological strategies, 1998-2008: a systematic literature review.

Authors:  Karan S Kverno; Betty S Black; Marie T Nolan; Peter V Rabins
Journal:  Int Psychogeriatr       Date:  2009-07-09       Impact factor: 3.878

9.  Use of atypical antipsychotics in the elderly.

Authors:  Elisa Cascade; Amir H Kalali; Jeffrey L Cummings
Journal:  Psychiatry (Edgmont)       Date:  2008-07

10.  Donepezil delays progression to AD in MCI subjects with depressive symptoms.

Authors:  P H Lu; S D Edland; E Teng; K Tingus; R C Petersen; J L Cummings
Journal:  Neurology       Date:  2009-06-16       Impact factor: 9.910

View more
  6 in total

1.  Dietary therapies for epilepsy and other neurological disorders: highlights of the 3rd international symposium.

Authors:  Carl E Stafstrom
Journal:  Epilepsy Curr       Date:  2013-03       Impact factor: 7.500

2.  [MRI in dementia-type diseases].

Authors:  S V Bodea; R Mühl-Benninghaus
Journal:  Radiologe       Date:  2015-05       Impact factor: 0.635

3.  Synaptic markers of cognitive decline in neurodegenerative diseases: a proteomic approach.

Authors:  Erika Bereczki; Rui M Branca; Paul T Francis; Joana B Pereira; Jean-Ha Baek; Tibor Hortobágyi; Bengt Winblad; Clive Ballard; Janne Lehtiö; Dag Aarsland
Journal:  Brain       Date:  2018-02-01       Impact factor: 13.501

4.  Isolation Housing Exacerbates Alzheimer's Disease-Like Pathophysiology in Aged APP/PS1 Mice.

Authors:  Huang Huang; Linmei Wang; Min Cao; Charles Marshall; Junying Gao; Na Xiao; Gang Hu; Ming Xiao
Journal:  Int J Neuropsychopharmacol       Date:  2015-01-07       Impact factor: 5.176

5.  Effects of a staged integral art-based cognitive intervention (SIACI) program in older adults with cognitive impairments: protocol for a randomized controlled trial.

Authors:  Yuan-Jiao Yan; Ming-Ping Ma; Wen-Chao Cai; Chen-Shan Huang; Rong Lin; Yu-Fei Chen; Hong Li
Journal:  BMC Geriatr       Date:  2022-04-07       Impact factor: 3.921

Review 6.  Preclinical non-human models to combat dementia.

Authors:  Avijit Banik; Akshay Anand
Journal:  Ann Neurosci       Date:  2013-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.